Close Menu

NEW YORK (GenomeWeb) – GenomeDx and pathology firm Pathnostics said today that they have entered a strategic agreement under which GenomeDx will market and distribute Pathnostics' Guidance UGx and Guidance PRx tests.

The two tests diagnose urinary tract infections (UTIs) and prostatitis, respectively. Both use quantitative PCR to detect the presence of pathogens and to measure molecular signs of antibiotic resistance. According to Pathnostics, this provides a faster and more comprehensive solution than traditional culture methods.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Mar
28
Sponsored by
Qiagen

The Human Gene Mutation Database (HGMD) is a manually curated, comprehensive collection of disease-causing, germline mutations. Since 1996, a team of experts has manually catalogued over a quarter of a million mutations for the database.  

Apr
11
Sponsored by
Bionano Genomics

This webinar will review a recent study that applied whole-genome sequencing and optical genome mapping to identify a large number of previously undetected somatic structural variants in leukemia samples.

Apr
17
Sponsored by
Isoplexis

This webinar will provide an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers.